Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06934265 · ClinicalTrials.gov registry record · NA
PhoRTE® Therapy Efficacy: In-Person Versus Telehealth
A NA study, sponsored by University of Southern California.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06934265 is a NA study that has not yet begun recruiting, run by University of Southern California. The registered enrollment target is 30 participants.
The verdict
NCT06934265, a NA study, has not yet begun recruiting, sponsored by University of Southern California.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study compares how well voice therapy works when delivered in-person versus through telehealth for older adults with age-related voice problems. Researchers are testing whether Phonation Resistance Training Exercises (PhoRTE®) can be just as effective when delivered remotely as when done face-to-face, which could make treatment more accessible and affordable for seniors. The two primary hypotheses are: 1. Does voice therapy (called PhoRTE®) work as well through video calls as it does face-to-face? 2. Can online therapy be a more accessible way for older adults to get help for their voice problems? Adults aged 55 or older with voice changes and an applicable diagnosis will be randomly assigned to receive either in-person or telehealth therapy, consisting of four 45-minute sessions. After treatment, researchers will measure improvements through: * Changes in voice function * Patient reports about their voice * Scientific measurements of voice quality * Patient satisfaction with treatment * Impact on quality of life The results will help determine if telehealth can be a good alternative to in-person voice therapy, especially important as telehealth coverage may be changing.
Interventions
- BEHAVIORAL exuberant voice therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-01-25 |
| Est. Completion | 2026-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06934265
The ClinicalTrials.gov registry entry for NCT06934265 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which exuberant voice therapy is the first listed.
NCT06934265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06934265 about?
NCT06934265 is a clinical study titled "PhoRTE® Therapy Efficacy: In-Person Versus Telehealth". This study compares how well voice therapy works when delivered in-person versus through telehealth for older adults with age-related voice problems. Researchers are testing whether Phonation Resistance Training Exercises (PhoRTE®) can be just as effective when delivered remotely as when done face-t...
What is the current status of trial NCT06934265?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-01-25. Estimated completion is 2026-10-25.
What interventions are being tested in trial NCT06934265?
The interventions under investigation include: exuberant voice therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06934265?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.